MTBI Predict

scientists in lab

Mild traumatic brain injury (mTBI), often referred to as concussion, can result in long-term disability due to persistent headaches, imbalance, memory disturbance, and poor mental health, and ~30% have not returned to work or sport at 12 months. 

mTBI-PREDICT is a long-term study that aims to identify the most accurate, reproducible and clinically practical biomarkers to better identify those at risk of long-term health issues after a head injury. This will be achieved through a harmonised program of detailed clinical phenotyping of acute mTBI patients coupled with state-of-the-art multimodal biomarker evaluation (brain imaging, fluid biomarkers, steroid hormones, visual, vestibular, and cerebral physiology). Our vision is to deliver a step change in the care of patients with mTBI and bring much needed advances in patient rehabilitation by revealing ground-breaking evidence to justify which biomarkers should be used to inform the diagnosis and early management of mTBI.

Civilians and military to take part in major study to improve concussion prognosis